Advanced Malignancies Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
Recruiting
  • Advanced Malignancies
  • Santa Monica, California
  • +6 more
2022-04-06
Apr 6, 2022
I
Completed
  • Advanced Malignancies
  • Beijing, Beijing, China
    Beijing Cancer Hospital
2022-03-29
Mar 29, 2022
P
Recruiting
  • Advanced Malignancies
  • +4 more
  • Chermside, Queensland, Australia
  • +10 more
2022-04-04
Apr 4, 2022
A
Recruiting
  • Advanced Malignancies
  • Advanced Cancer
  • Atlanta, Georgia
  • +3 more
2022-03-21
Mar 21, 2022
N
Active, not recruiting
  • Advanced Malignancies
  • Baltimore, Maryland
  • +13 more
2022-03-18
Mar 18, 2022
B
Recruiting
  • Advanced Malignancies
  • BI-1808
  • Pembrolizumab 25 Mg/mL Solution for Injection
  • Copenhagen, Denmark
  • +7 more
2022-03-16
Mar 16, 2022
P
Active, not recruiting
  • Advanced Malignancies
  • Non-small-cell Lung Cancer
  • Beijing, Beijing, China
  • +52 more
2022-03-15
Mar 15, 2022
I
S
Recruiting
  • Advanced Malignancies
  • TWP-102 injection
  • Harbin, Heilongjiang, China
    Harbin Medical University Cancer Hospital
2022-03-07
Mar 7, 2022
B
Enrolling by invitation
  • Advanced Malignancies
  • Tislelizumab 200 mg, IV
  • +4 more
  • Miami Beach, Florida
  • +50 more
2022-03-04
Mar 4, 2022
I
Not yet recruiting
  • Advanced Malignancies
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
2022-02-08
Feb 8, 2022
B
Recruiting
  • Advanced Malignancies
  • Recombinant Humanized Monoclonal Antibody MIL93
  • Beijing, China
    Cancer Hospital,Chinese Academy of Medical Sciences and Peking U
2022-02-13
Feb 13, 2022
B
Recruiting
  • Advanced Malignancies
  • Recombinant Humanized Monoclonal Antibody MIL95
  • Beijing, China
    Beijing Cancer Hospital
2022-02-14
Feb 14, 2022
P
Completed
  • Small Cell Lung Cancer
  • +7 more
  • Scottsdale, Arizona
  • +4 more
2022-02-04
Feb 4, 2022
R
Recruiting
  • Advanced Malignancies
  • Nagoya, Aichi, Japan
  • +20 more
2022-01-07
Jan 7, 2022
E
Recruiting
  • All Malignancies
  • +11 more
  • Encinitas, California
  • +9 more
2021-12-15
Dec 15, 2021
S
Active, not recruiting
  • Advanced Malignancies
  • Toripalimab, Recombinant Humanized anti-PD-1 Monoclonal Antibody
  • Santa Monica, California
  • +13 more
2021-12-12
Dec 12, 2021
J
Recruiting
  • Advanced Malignancies
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
2021-10-31
Oct 31, 2021
I
Recruiting
  • Advanced Malignancies
  • Shanghai, Shanghai, China
    Shang Hai Pulmonary Hospital
2021-09-03
Sep 3, 2021
I
Terminated
  • Advanced Malignancies
  • Metastatic Cancer
  • Los Angeles, California
  • +1 more
2021-07-01
Jul 1, 2021